Skip to content

CaSE announces three new organisational members

21 Jan 2019

CaSE are delighted to welcome Anglia Ruskin University, MSD and PraxisAuril as new organisational members.

Commenting on the announcement, Dr Sarah Main, Executive Director of the Campaign for the Science and Engineering, said:

“I am delighted to welcome Anglia Ruskin, MSD and PraxisAuril as new members of CaSE. With these organisations joining today, CaSE now represents one hundred and seventeen organisations from across the science and engineering sector, the largest figure in its history.

These three new members, representing academia, business, and knowledge exchange, will add to our already diverse membership and ensure that CaSE remains a strong, independent and authoritative voice for science and engineering. 

We look forward to working with them all in helping to secure the skills, funding and policies to enable UK science and engineering to thrive”

Professor Roderick Watkins, Acting Vice Chancellor of Anglia Ruskin University:

“Science and engineering – ranging from public health to animal biology to built environment – are among Anglia Ruskin’s core areas of expertise. In the autumn we signed a partnership with Public Health England to carry out research and to develop the workforce at their new headquarters in Harlow. And we are investing in a range of cutting-edge facilities ourselves, having recently opened Britain’s newest School of Medicine in Chelmsford and a £45million science centre on our Cambridge campus.

“We are therefore delighted to be joining CaSE, helping to develop the education, skills and research agendas within science and engineering, as well as highlighting the importance of the sector to the wider community.”

 Laura Newby, Associate Director of Policy and Government Relations, MSD:

“MSD is delighted to join the Campaign for Science and Engineering in 2019.  The Campaign’s work to support the UK science base is valuable, and strongly evidence led.  MSD is committed to implementing the vision for a vibrant life sciences environment here in the UK and values this opportunity to engage with the wider science and engineering community.”

Maxine Ficarra, CEO, PraxisAuril:

“I’m delighted that PraxisAuril is becoming a member of CaSE and adding our members’ expertise to the campaign. PraxisAuril represents professionals working in Knowledge Exchange in universities and research institutions: a strong and diverse UK research base is fundamental to their work and we believe that it should be protected and funded to thrive.

Our members sit at the interface between researchers and external collaborators so being part of conversations that bring these ‘two worlds’ together is vital to our mission. CaSE’s broad membership will enable us to have more of those good conversations going forward, providing opportunities for PraxisAuril contribute to innovation policy and practice.”

About Anglia Ruskin University

Anglia Ruskin is an innovative global university, brimming with ambition. Students from 177 countries gain qualifications with us in four continents.  Students, academics, businesses and partners all benefit from our outstanding facilities; we’ve invested £100 million over the last five years and plan to invest a further £91 million over the next five years. Anglia Ruskin’s Research Institutes and four faculties bridge scientific, technical and creative fields.  We deliver impactful research which tackles pressing issues and makes a real difference, from saving lives to conserving water.  Our academic excellence has been recognised by the UK’s Higher Education funding bodies, with 12 areas classed as generating world-leading research. We are ranked in the world’s top 350 institutions in the 2019 Times Higher Education World University Rankings, and in 2016 we featured in a list of the 20 ‘rising stars’ in global Higher Education compiled by strategy consultants Firetail.

About MSD 

For more than a century, MSD, a leading global biopharmaceutical company, has been inventing for life, bringing forward medicines and vaccines for the world’s most challenging diseases. Through our prescription medicines, vaccines, biologic therapies and animal health products, we work with customers and operate in more than 140 countries to deliver innovative health solutions. We also demonstrate our commitment to increasing access to health care through far-reaching policies, programmes and partnerships. Today, MSD continues to be at the forefront of research to advance the prevention and treatment of diseases that threaten people and communities around the world.

About PraxisAuril

Successful Knowledge Exchange and Commercialisation (KEC) is essential to the economic growth of the UK. PraxisAuril supports KEC in the UK and works with key stakeholders and partners to promote best practice in the sector. PraxisAuril develops knowledge exchange and technology transfer professionals though our world-leading training, connecting members and stakeholders at our events, and promoting best practice for our sector. We facilitate interactions between the public sector research base, business and government; bringing together key stakeholders to debate, educate and inform.